STOCK TITAN

Airsculpt Technologies, Inc. - AIRS STOCK NEWS

Welcome to our dedicated page for Airsculpt Technologies news (Ticker: AIRS), a resource for investors and traders seeking the latest updates and insights on Airsculpt Technologies stock.

About AirSculpt Technologies, Inc.

AirSculpt Technologies, Inc. (NASDAQ: AIRS) is a leading provider of premium body contouring procedures, operating under its exclusive brand, Elite Body Sculpture. The company specializes in delivering minimally invasive fat removal and body sculpting treatments using its patented AirSculpt® technology. Designed to optimize precision and patient comfort, the AirSculpt® procedure offers a modern alternative to traditional liposuction by combining fat removal and skin tightening in a single treatment. This innovative approach allows for faster healing, minimal bruising, and natural-looking results, catering to patients seeking advanced aesthetic solutions.

Business Model and Operations

AirSculpt operates a direct-to-consumer business model, with revenue generated through elective medical procedures performed at its dedicated clinics. The company employs an asset-light business strategy, focusing on operating premium centers equipped with state-of-the-art technology. Each location is designed to enhance the patient experience, providing a luxurious and comfortable environment. Currently, AirSculpt has expanded its presence to over 30 locations across the United States, Canada, and the United Kingdom, with plans for continued growth in response to increasing consumer demand for its services.

Proprietary Technology and Differentiation

At the core of AirSculpt's value proposition is its proprietary AirSculpt® technology, a minimally invasive fat removal method that uses a patented technique to remove unwanted fat while simultaneously tightening the skin. Unlike traditional liposuction, AirSculpt requires no general anesthesia, reduces trauma to surrounding tissues, and enables quicker recovery times. The company has also developed complementary procedures, such as AirSculpt®+ skin tightening and AirSculpt® Lift, which further enhance its offerings by addressing skin laxity and facial rejuvenation.

Market Position and Industry Context

AirSculpt Technologies operates within the growing aesthetics and body contouring market, a sector driven by rising consumer interest in minimally invasive cosmetic procedures. The company's unique technology and premium branding position it as a key player in this space, competing with both surgical and non-surgical alternatives. Its focus on delivering consistent, high-quality results has contributed to a strong reputation among patients, with more than 70,000 procedures successfully performed since its inception in 2012.

Challenges and Competitive Landscape

While AirSculpt benefits from a differentiated product offering and growing market demand, it faces competition from traditional liposuction providers and emerging non-invasive technologies such as CoolSculpting and laser-based fat reduction methods. Additionally, the elective nature of its procedures makes it sensitive to economic fluctuations. To mitigate these challenges, the company emphasizes innovation, operational efficiency, and strategic location expansion to capture a larger share of the addressable market.

Future Outlook

AirSculpt Technologies is well-positioned to capitalize on the increasing demand for aesthetic procedures. With a focus on expanding its clinic network, enhancing operational efficiencies, and leveraging its proprietary technology, the company aims to drive long-term growth and profitability. Its commitment to delivering exceptional patient outcomes and maintaining a strong brand presence underscores its potential for continued success in the competitive body contouring market.

Rhea-AI Summary
AirSculpt Technologies, Inc. will report its Q3 2023 financial results on November 10, 2023. A conference call will be held at 8:30 a.m. ET on the same day. The webcast can be accessed on the company's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.06%
Tags
-
Rhea-AI Summary
AirSculpt Technologies partners with Joey Fatone to share his experience with their premium body contouring procedures
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.88%
Tags
partnership
-
Rhea-AI Summary
AirSculpt Technologies, Inc. announces unaudited preliminary financial results for Q3 2023, with revenue expected to be approximately $46.5 million, representing a 20.0% increase over the prior year. The company also updates its 2023 revenue guidance to approximately $196 million and expects to achieve at least $45 million in Adjusted EBITDA.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.28%
Tags
Rhea-AI Summary
AirSculpt® Technologies, Inc. announces opening of new center in Raleigh, NC, increasing total center count to 27 locations. AirSculpt® is a next-generation body contouring treatment designed for comfort and precision. Over 40,000 AirSculpt cases performed in premium locations throughout the US, Canada, and the UK.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.95%
Tags
none
-
Rhea-AI Summary
AirSculpt Technologies introduces AirSculpt Lift as a safe and natural alternative to synthetic dermal fillers for eliminating wrinkles and restoring volume to the face.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.92%
Tags
none
-
Rhea-AI Summary
AirSculpt Technologies, a provider of body contouring procedures, announced Q2 2023 results. Cases increased by 13.4% to 4,186, revenue increased by 12.2% to $55.7 million, and net income was $1.8 million. The company opened a new center in London and plans to open another in Q3. Full-year revenue guidance is $187-$192 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.78%
Tags
Rhea-AI Summary
AIRS: AirSculpt® Technologies, Inc. to Feature Jenny McCarthy's AirSculpt Experience on Instagram Live. Dr. Aaron Rollins, Founder and Executive Chairman, to Join the Discussion with Jenny McCarthy on August 7. The event will showcase Jenny's dramatic transformation and her experience with AirSculpt premium body contouring procedures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.23%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.55%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.82%
Tags
none

FAQ

What is the current stock price of Airsculpt Technologies (AIRS)?

The current stock price of Airsculpt Technologies (AIRS) is $4.05 as of March 3, 2025.

What is the market cap of Airsculpt Technologies (AIRS)?

The market cap of Airsculpt Technologies (AIRS) is approximately 259.6M.

What is AirSculpt Technologies, Inc.?

AirSculpt Technologies, Inc. specializes in minimally invasive body contouring procedures using its proprietary AirSculpt® technology.

How does AirSculpt® technology differ from traditional liposuction?

AirSculpt® is a minimally invasive procedure that removes fat and tightens skin without general anesthesia, offering faster recovery and less bruising compared to traditional liposuction.

How does AirSculpt Technologies generate revenue?

The company generates revenue through direct payments for its elective body contouring procedures performed at its dedicated clinics.

What is the competitive advantage of AirSculpt Technologies?

AirSculpt's proprietary technology, premium branding, and focus on patient comfort and precision differentiate it from competitors in the body contouring market.

What are the main challenges AirSculpt Technologies faces?

Key challenges include competition from other aesthetic procedure providers, regulatory compliance, and economic sensitivity due to the elective nature of its services.

Where are AirSculpt clinics located?

AirSculpt operates over 30 clinics across the U.S., Canada, and the United Kingdom, with plans for continued expansion.

What additional procedures does AirSculpt offer?

In addition to fat removal, AirSculpt offers complementary procedures like AirSculpt®+ skin tightening and AirSculpt® Lift for facial rejuvenation.

Who are AirSculpt Technologies' competitors?

Competitors include traditional liposuction providers, non-invasive technologies like CoolSculpting, and other aesthetic procedure providers.

What is the company's growth strategy?

AirSculpt focuses on expanding its clinic network, enhancing operational efficiencies, and leveraging its proprietary technology to capture market demand.

What is the market outlook for body contouring procedures?

The body contouring market is growing due to increasing consumer interest in minimally invasive aesthetic treatments and advancements in technology.
Airsculpt Technologies, Inc.

Nasdaq:AIRS

AIRS Rankings

AIRS Stock Data

259.60M
12.92M
26.91%
73.11%
5.1%
Medical Care Facilities
Services-offices & Clinics of Doctors of Medicine
Link
United States
MIAMI BEACH